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ABSTRACT Host cytokine responses to Brucella abortus infection are elicited predominantly by the deployment of a type IV se-
cretion system (T4SS). However, the mechanism by which the T4SS elicits inflammation remains unknown. Here we show that
translocation of the T4SS substrate VceC into host cells induces proinflammatory responses. Ectopically expressed VceC inter-
acted with the endoplasmic reticulum (ER) chaperone BiP/Grp78 and localized to the ER of HeLa cells. ER localization of VceC
required a transmembrane domain in its N terminus. Notably, the expression of VceC resulted in reorganization of ER struc-
tures. In macrophages, VceC was required for B. abortus-induced inflammation by induction of the unfolded protein response
by a process requiring inositol-requiring transmembrane kinase/endonuclease 1. Altogether, these findings suggest that translo-
cation of the T4SS effector VceC induces ER stress, which results in the induction of proinflammatory host cell responses during
B. abortus infection.
IMPORTANCE Brucella species are pathogens that require a type IV secretion system (T4SS) to survive in host cells and to main-
tain chronic infection. By as-yet-unknown pathways, the T4SS also elicits inflammatory responses in infected cells. Here we
show that inflammation caused by the T4SS results in part from the sensing of a T4SS substrate, VceC, that localizes to the endo-
plasmic reticulum (ER), an intracellular site of Brucella replication. Possibly via binding of the ER chaperone BiP, VceC causes
ER stress with concomitant expression of proinflammatory cytokines. Thus, induction of the unfolded protein response may
represent a novel pathway by which host cells can detect pathogens deploying a T4SS.
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Both commensals and nonpathogenic bacteria producepathogen-associated molecular patterns (PAMPs) that stim-
ulate innate immune responses in their eukaryotic hosts via pat-
tern recognition receptors such as Toll-like receptors (TLRs). Im-
portantly, virulence factors of pathogens provide additional
signals that allow the innate immune system to differentiate be-
tween friend and foe (1). These factors include type III and IV
secretion systems (T3SS and T4SS, respectively) that translocate
bacterial PAMPs such as flagellin, peptidoglycan, or nucleic acids
into the host cell cytosol, thereby activating cytosolic signaling
pathways such as Nod-like receptors that induce proinflamma-
tory cytokine expression via caspase-1 inflammasomes and acti-
vation of NF-B (2, 3). In addition, both mammalian and plant
hosts can sense interference by bacterial T3SS and T4SS effectors
with critical signaling pathways such as signal transduction and
translation by detecting “patterns of pathogenesis” (4–6).
The intracellular bacterial pathogen Brucella abortus is a good
model for the identification of patterns of pathogenesis, because
its PAMPs, such as lipopolysaccharide and flagellin, have very
weak agonist activity for TLRs (7–9). The induction of inflamma-
tion by B. abortus in vivo is, for the most part, dependent on the
activity of a T4SS. In a mouse infection model, this proinflamma-
tory stimulus results in the induction of granulomatous inflam-
mation and Th1 polarization of the immune response (10–12).
However, the mechanism by which this response is elicited by the
T4SS and the host cell pathways involved are unknown.
The T4SS of the human-pathogenic Brucella species (B. abor-
tus, B. suis, and B. melitensis) is essential for persistent infection in
cultured macrophages, in mice, and in goats, the latter being an
important zoonotic reservoir host of B. melitensis (13–18). In
macrophages, a primary target of Brucella during infection, ex-
pression of the T4SS-encoding virB operon is induced after acid-
ification of the Brucella-containing vacuole (BCV) (19). The Bru-
cella T4SS mediates the exclusion of phagolysosomal markers
from the endosomal BCV and maturation to an endoplasmic re-
ticulum (ER)-derived compartment (20–22). As a result, intracel-
lular B. abortus can avoid degradation in phagolysosomes and,
instead, this bacterium is found initially within vacuoles contain-
ing ER markers such as calreticulin (22). Later in infection, the
bacteria localize to large, LAMP-1-positive vacuoles with features
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of autophagosomes, named aBCVs (23). As virB mutant Brucella
strains remain in lysosomal compartments and fail to replicate, it
is thought that T4SS effectorsmay contribute to this subversion of
the endocytic pathway.
Multiple reports have identified Brucella proteins whose trans-
location into the host cytosol is directly or indirectly dependent on
the T4SS (13, 24, 25). One of these proteins, VceC, is translocated
in a T4SS-dependent manner into macrophages during infection
with B. abortus. However, its function and contribution to Bru-
cella infection were so far unknown (13). In this study, we identi-
fied a host pathway involved in the sensing of VceC translocation
into host cells, unveiling the first known intracellular activity for a
T4SS substrate of B. abortus.
RESULTS
VceC is involved in induction of proinflammatory cytokines by
the B. abortus T4SS. The VirB T4SS is involved in several aspects
of host-pathogen interactions, including intracellular replication
(16, 17), exclusion of LAMP-1, and targeting to the ER (20), and
maintaining infection in both mice and goats (15, 18, 29). Fur-
thermore, in vivo, the T4SS induces inflammatory responses early
during infection (10, 12). To study the contribution of VceC to
these T4SS-dependent phenotypes, a B. abortus mutant lacking
the entire vceC gene (MDJ32) was constructed (see Fig. S1A in the
supplementalmaterial). The absence of vceC expression inMDJ32
was confirmed by Western blotting (see Fig. S1B). Notably, the
vceC mutant (MDJ32) was able to survive and replicate inside
both macrophages and HeLa cells to a level comparable to that of
the wild-type B. abortus strain (see Fig. S1C and S2). Similar to
wild-type B. abortus, the vceC mutant strain was able to exclude
the late endosomal/lysosomal marker LAMP-1 and target to the
ER, as evidenced by the colocalization of bacteria with calnexin at
24 h (see Fig. S2) (21). Also, the late targeting of B. abortus to
aBCVs was unaffected at 72 h (see Fig. S2) (23). In the mouse
infection model, strain MDJ32 (vceC) colonized mice initially at
wild-type levels. However, at 4 and 8 weeks postinfection (p.i.), a
small (50%) but statistically significant competitive defect in
splenic colonization by MDJ32 (vceC) was observed (see
Fig. S1D). These observations suggest that even though VceC is
dispensable for persistence, it does enhance persistent coloniza-
tion of the spleen in the mouse infection model.
In addition to survival in macrophages, the T4SS of B. abortus
and B. melitensis was previously found to be required for the in-
duction of genes encoding cytokines and chemokines in the
spleens of infectedmice (12). It can therefore be hypothesized that
induction of the host’s innate immune system by the Brucella
T4SS is triggered directly, through the recognition of one or more
of its effectors by host cells. To test whether VceC contributes to
the T4SS-induced inflammation phenotype, we infected mouse
bone marrow-derived macrophages (BMDM) with the B. abortus
wild-type strain (2308); the T4SS-deficient virB2 strain (ADH3),
which lacks a predicted pilus protein; the vceC mutant strain
(MDJ32); or a complemented vceC mutant. The results showed
that wild-type B. abortus induces the secretion of proinflamma-
tory cytokines interleukin-6 (IL-6) and tumor necrosis factor al-
pha (TNF-), whereas relatively low levels of these cytokines were
detected in the supernatants of uninfected macrophages (Fig. 1A
and C). Compared to the wild-type strain, the B. abortus virB2
mutant strain induced lower levels of cytokines, consistent with
the observed in vivo proinflammatory role of the Brucella T4SS.
Interestingly, infection of the macrophages with the vceCmutant
also induced lower secretion of IL-6 and TNF- than did wild-
type B. abortus and this defect was restored by complementation
of the vceC mutant strain with a plasmid-borne copy of vceC
(Fig. 1A to D). Since production of gamma interferon (IFN-) by
CD4 T cells is essential for control of B. abortus infection in vivo
(30), we also determined whether VceC has the same activity in
IFN--activated macrophages (Fig. 1B and D). In IFN--
activated BMDM, we observed a more marked difference in IL-6
and TNF- production by cells infected with wild-type B. abortus
or the complemented vceCmutant than in those infected with the
vceCmutant (Fig. 1B andD). These differences were not the result
of differences in bacterial numbers, since compared to wild-type
B. abortus, equal or higher numbers of mutant bacteria were pres-
ent in the cells at 24 h p.i. (Fig. 1E and F). The VceC-dependent
induction of TNF- and IL-6 in infected macrophages suggests
that VceC is sensed by an innate immune pathway in the cell that
leads to downstream activation of NF-B.
FIG 1 VceC is required for B. abortus-induced secretion of IL-6 and TNF-
(A toD). BMDMwere infected for 24 hwithwild-type (WT)B. abortus (2308),
the virB2 mutant (ADH3), the vceC mutant (MDJ32), or the complemented
vceC mutant (MDJ71). Macrophages were either left untreated (A, C) or
treated with 1 ng/ml IFN- (B, D) during infection. Levels of IL-6 (A, B) or
TNF- (C, D) in themacrophage supernatants weremeasured by ELISA. Data
are expressed as means  standard deviations and represent the results of a
single experiment that was replicated three times independently with similar
results. (E and F) Intracellular numbers of B. abortus CFU in BMDMwith (E)
and without (F) IFN- treatment.
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To confirm the in vitro role of VceC in the induction of inflam-
mation in an in vivo model, C57BL/6 mice were either mock in-
fected or infected with the B. abortus wild-type, virB2 mutant
(ADH3), or vceCmutant (MDJ32) strain. As controls, a group of
mice was mock infected. Inflammatory changes were evaluated at
14 days p.i. (Fig. 2). The virB2mutant was present in the spleen in
reduced numbers compared to wild-type B. abortus, as demon-
strated previously (31), while the vceC mutant colonized the
spleen in numbers equal to those of the wild type (Fig. 2A). How-
ever, at this time point, circulating IL-6 levels were significantly
lower in vceCmutant-infectedmice than inmice infected with the
wild-type strain (P 0.03; Fig. 2B). Furthermore, a second mea-
sure of inflammatory changes, namely, spleen weight, was signif-
icantly reduced in mice infected with the vceCmutant (P 0.02;
Fig. 2C). This result suggests that T4SS-mediated translocation of
VceC contributes to inflammation during the infection ofmice by
B. abortus.
VceC interactswith the ER chaperoneBiP.To identify poten-
tial interaction partners of VceC that could contribute to its pro-
inflammatory activity, we performed immunoprecipitation (IP)
with HeLa cells expressing the enhanced-GFP (eGFP)-VceC or
Myc-VceC fusion. In Fig. 3A, the IP fraction from cells expressing
eGFP-VceC was resolved by SDS-PAGE, revealing two additional
FIG 2 Groups of four C57BL/6 mice were infected with wild-type (WT)
B. abortus (2308), the virB2 mutant ADH3, or the vceC mutant MDJ32 and
euthanized at day 14. (A) Total bacterial loads in mouse spleens. (B) Levels of
circulating IL-6measured by ELISA. (C) Spleen weights of infectedmice. Data
are expressed as means  standard deviations, and the significance of differ-
ences was analyzed with a two-tailed Student t test.
FIG 3 Interaction of VceC with the host ER chaperone BiP. (A) IP with
anti-GFP antibodies was performed with HeLa cells expressing GFP-VceC,
and the resulting IP fractions were resolved by SDS-PAGE and silver stained.
Bands of 70 and 78 kDa, visible in the IP fraction of GFP-VceC were excised
from the gel and subjected to LC-MS analysis. Asterisks indicate bands corre-
sponding to the heavy and light chains of immunoglobulin. (B) Western blot
probed with anti-BiP antibody showing the presence of BiP in the IP fraction
ofMyc-VceC-transfected cells but not in the IP fraction of untransfected cells.
IPwas performedwith an antibody against theMyc tag. (C) Proteins identified
by LC-MS in the IP fraction of GFP-, GFP-VceC-, or GFP-VceC5-167-
transfected HeLa cells. -GFP, anti-GFP antibody.
B. abortus VceC Stimulates the UPR
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bands of 70 and 78 kDa. Both the 70- and 78-kDa bands were
subjected to LC-MS analysis (Fig. 3A).While the 70-kDa bandwas
found to be Hsp70, a cytosolic chaperone, the 78-kDa band was
identified as BiP/Grp78. BiP is a chaperone found in the lumen of
the ER, where it plays a key role in protein secretion and in the
maintenance of ER homeostasis (32–35). Of these two bands, only
the BiP/Grp78 bandwas specific forVceC,whileHsp70was pulled
down in cells transfected with both eGFP-VceC and eGFP-VceA
(a second B. abortus T4SS substrate, not shown in Fig. 3) and
therefore was not analyzed further as a specific interaction partner
of VceC.
To determine whether the interaction of GFP-VceC with BiP
was related to the relatively large GFP moiety, the IP experiment
was repeated with HeLa cells transiently transfected with a con-
struct encoding VceC fused to the smaller Myc tag (Myc-VceC;
Fig. 3B).Western blotting demonstrated the presence of BiP in the
IP fraction of Myc-VceC-transfected HeLa cells but not in the IP
fraction of untransfected cells.
VceC contains a central proline-rich region in which proline
accounts for 25% of the amino acid residues. Since proline-rich
domains have been implicated in protein-protein interactions of
both bacterial and host factors (36–38), we also tested whether the
proline-rich region of VceC is required for binding to BiP by re-
peating the IP experiments with HeLa cells expressing eGFP,
eGFP-VceC, or eGFP-VceC5-167, lacking the proline-rich region
of VceC. As expected, LC-MS analysis identified peptides match-
ing the GFP sequence in all three IP fractions and VceC peptides
were detected only in the samples containing VceC or VceC5-167
(Fig. 3C). BiPwas immunoprecipitated by bothVceC andVceC5-167,
indicating that the proline-rich region is not required for interaction
with BiP.
Ectopically expressed VceC localizes to the ER in HeLa cells
and alters its structure. The finding that VceC interacts with BiP,
a protein localizing to the ER, prompted us to examine the sub-
cellular localization of VceC in HeLa cells (Fig. 4). Confocal mi-
croscopy of cells ectopically expressing HA-VceC revealed that it
colocalized with the ERmarker calreticulin (Fig. 4A). Notably, the
normal, fine reticular pattern of ER staining in cells expressing
HA-VceC was disrupted compared to that in untransfected HeLa
cells (Fig. 4A), as HA-VceC reorganized the ER into thicker tubu-
lar structures (Fig. 4A). This disruption of the ER structure re-
quired theN terminus ofVceC, since truncation of theN-terminal
37 amino acids of VceC resulted in a variant that no longer tar-
geted the ER or led to its reorganization (Fig. 4B). To ensure that
the effect of HA-VceC on the ER was independent of the epitope
tag, experiments were repeated with Myc-VceC and GFP-VceC
fusions that were expressed in a similar manner. Similar to HA-
VceC,Myc-VceC andGFP-VceC both localized to the ER of HeLa
cells (GFP-VceC: Fig. 5B; Myc-VceC not shown) and also dis-
rupted the ER structure of these cells. Expression of VceC did not
lead to an overall disruption of cellular architecture, since the
actin cytoskeleton appeared unchanged in cells expressing VceC
(Fig. 4C).
Since Brucella is known to infect primarily phagocytic cells, the
localization of VceC in transfected RAW264.7 mouse macro-
phages was determined (Fig. 4D). Similar to what was observed in
HeLa cells, HA-VceC localized to the ER of RAW264.7 cells and
the ER network. Taken together, these results indicate that VceC
targets the ER, the subcellular compartment from which the
B. abortus replication niche is derived.
VceC requires a hydrophobic domain at its N terminus for
ER localization. In addition to the proline-rich regionmentioned
above, B. abortus VceC is predicted to contain a hydrophobic TM
domain at its N terminus (Fig. 5A). To determine the regions of
VceC required for ER localization, a series of truncated VceC pro-
teins lacking the N-terminal TM domain (VceC38-418), a
C-terminal domain (VceC5-325), or the central proline-rich do-
main (VceC5-167) was expressed in HeLa cells (Fig. 5). Both GFP-
VceC5-325, truncated at the C terminus, and GFP-VceC5-167, lack-
ing both the C terminus and the proline-rich region, localized to
the ER. The ER structures of HeLa cells expressing GFP-VceC5-325
and GFP-VceC5-167 appeared to be disrupted similarly to that of
cells expressing full-length VceC, suggesting that neither the C
terminus nor the proline-rich region is required for perturbation
of the ER structure upon the expression of VceC (Fig. 5B). How-
ever, in contrast to full-length VceC, VceC38-418 did not localize to
the ER, but rather was distributed diffusely in the cytoplasm
(Fig. 5B), suggesting that the N-terminal 37 amino acids contain-
ing the predicted TM domain are required for ER localization of
VceC. VceC38-418 also failed to colocalize with BiP (Fig. 5C), sug-
gesting that this interaction requires the localization of VceC to
the ER.
The proinflammatory response induced by VceC shares fea-
tures with the ER stress response. BiP/Grp78, identified above as
FIG 4 Localization ofHA-VceC fusions inHeLa cells (A to C) and RAW264.7
macrophages (D). Transfected cells grown on coverslips were stained with
anti-calreticulin antibody (red) tovisualize theER(A,B, andD)orwithphalloidin
(red) to visualize the actin cytoskeleton (C). HA-VceC and HA-VceC38-418 were
visualizedwith anti-HAantibody (green). The images shown are representative of
at least three independent experiments.
de Jong et al.
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an interaction partner of VceC, plays a central role in the mainte-
nance of ER homeostasis. Under homeostatic conditions, BiP se-
questers ER membrane proteins that function in the unfolded
protein response (UPR), including the double-stranded-RNA-
dependent protein kinase-like ER kinase (PERK), activating tran-
scription factor 6 (ATF6), and inositol-requiring TM kinase/en-
donuclease 1 (IRE1), thereby preventing their activation
(reviewed in reference 39). Perturbation of the ER, for example,
via accumulation of unfolded proteins,
results in recruitment of BiP to the un-
folded proteins, thereby releasing it from
PERK, ATF6, and IRE1, which permits
the activation of these proteins by phos-
phorylation and initiation of the UPR.
We hypothesized that during infec-
tion, translocation of VceC into host cells,
followed by VceC targeting to the ER and
binding to BiP, could lead to activation of
the UPR. To test this hypothesis, we in-
fected BMDM with the B. abortus wild
type, the vceC mutant (MDJ32), or the
complemented vceC mutant and mea-
sured the induction of IL-6, the induction
of the ER stress markers BiP (40) and
Sec61 (41), and the splicing of the XBP1
mRNA (27, 42). As a positive control for
ER stress and UPR induction, uninfected
macrophages were treated with tunica-
mycin (41, 43, 44). Interestingly, treat-
ment of macrophages with tunicamycin
induced IL-6 expression to an extent sim-
ilar to that of infection with B. abortus
(Fig. 6A), consistent with a possible asso-
ciation between the UPR and the inflam-
matory response induced by VceC. A fea-
ture of the UPR is upregulation of
proteins that relieve ER stress, including
BiP and Sec61, a component of the
Sec61 translocon (39). Infection with
B. abortus or treatment with tunicamycin
resulted in increased levels of both hspa5
(encoding BiP) and sec61g (encoding
Sec61) transcripts (Fig. 6B and C). The
increased expression of these genes was
dependent on VceC, and the reduced in-
duction observed during infection with
the vceCmutant was restored in the com-
plemented strain.
A second feature of ER stress is splicing
of the mRNA for the transcription factor
XBP1, which occurs when BiP is released
from the ER-localized splicing enzyme
IRE1. The splicing of XBP1mRNA allows
for its translation to form a stable protein
(39). This splicing was reduced in cells in-
fected with the vceC mutant and was re-
stored in cells infected with the comple-
mented vceCmutant (Fig. 6D).
To determine whether ER stress is re-
quired for sensing of VceC translocation
during infection with B. abortus, we knocked down the expression
of IRE1 in BMDM by using siRNA (Fig. 6E to G). In BMDM
treated with siRNA, expression of IRE1 was reduced by 75%, on
average (Fig. 6E). Further, knockdown of IRE1 in BMDMdid not
affect the bacterial numbers of B. abortus at 24 h p.i. (Fig. 6F).
Knockdown of IRE1 expression resulted in a significant reduction
of IL-6 secretion by BMDM infected with wild-type B. abortus, or
treated with tunicamycin, demonstrating that in both cases, the
FIG 5 Localizations of GFP-VceC truncations in HeLa cells. (A) Schematic representation of B. abor-
tus VceC showing the putative TM domain and the proline-rich (PR) region. Also shown are the
observed localizations of the fusion proteins and their disruptive influences on the integrity of the ER.
(B) Localization of theGFP-VceC fusion protein in the cytoplasm or ER ofHeLa cells. Colocalization of
GFPwith the ERmarker calreticulin was used to determine the ER localization of the GFP-VceC fusion
protein. (C) Colocalization of VceC, but not VceC38-418, with BiP. The results shown are representative
images from at least three independent experiments.
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proinflammatory signaling depended on the UPR (Fig. 6G). In
contrast, IRE1 knockdown did not affect IL-6 secretion induced
by the virB2 or vceC mutant. These results implicate the UPR in
the sensing of VceC translocation by B. abortus in infected mac-
rophages.
VceC-induced NF-B activation requires its localization to
the ER. The results presented above suggest that the translocation
of VceC into host cells leads to its localiza-
tion to the ER, where it is sensed by an ER
stress pathway that leads to the activation
of NF-B-dependent cytokines. To verify
these results byusingadifferent experimen-
tal approach and to eliminate the influence
of other Brucella factors, we ectopically ex-
pressed HA-VceC in HEK293 cells that
were transfected with an NF-B luciferase
reporter construct. While the expression of
full-lengthHA-VceC resulted inNF-B ac-
tivation, HA-VceC38-418, lacking the TM
domain required for ER targeting (Fig. 5B),
failed to activate NF-B above the level of
the empty control plasmid (Fig. 7), suggest-
ing that ER targeting ofVceC is required for
its proinflammatory activity.
DISCUSSION
The ER functions in the biosynthesis,
folding, and modification of both soluble
and membrane proteins, as well as in the
maintenance of calcium homeostasis.
Perturbations of cellular physiology that
disrupt these functions can lead to the ac-
cumulation of unfolded or misfolded
proteins in the ER lumen, a condition
known as ER stress (33). Tomaintain cel-
lular homeostasis, the UPR is induced.
This response involves multiple pathways
that alter both transcription and transla-
tion, thereby allowing the cell to resolve
ER stress by reducing the influx of new
proteins into the ER (39).
Our results suggest that the T4SS-
secreted protein VceC can also trigger the
UPR, resulting in the induction of inflam-
mation by B. abortus. A connection be-
tween ER stress and NF-B signaling was
discovered almost 20 years ago (44, 45).
More recently, it has been shown that
both infectious and noninfectious pro-
cesses can trigger ER stress and UPR-
dependent NF-B signaling, including
cleavage of BiP by the subtilase cytotoxin
of enterohemorrhagic Escherichia coli
(46) and retention of antigen in the ER of
B lymphocytes (47).Our results show that
the induction of this pathway by a se-
creted bacterial effector, VceC, might
serve as a pattern of pathogenesis that in-
duces inflammation. Interestingly, a
group of Legionella pneumophila T4SS ef-
fectors activates NF-B signaling by in-
hibiting protein synthesis in infected host cells (5). Since inhibi-
tion of translation is a downstream component of the UPR, our
results suggest that different points in the same pathway can be
targeted by diverse bacterial proteins.
While our results suggest that VceC-mediated induction of the
UPR triggers proinflammatory responses, it is unclear whether
this is dependent on the interaction between VceC and BiP. BiP
FIG 6 VceC-dependent induction of IL-6 and ER stress markers in BMDM infected with B. abortus.
RNA was isolated from macrophages that had been infected for 24 h with wild-type (wt or WT)
B. abortus (2308), the vceCmutant MDJ32, or the complemented vceCmutant MDJ71 or treated with
3.5 g/ml tunicamycin. All cells were treated with 1 ng/ml IFN- for 24 h. (A to C) Levels of IL-6 (A),
hspA5 (BiP; B), and sec61g (C) mRNAs were determined by qRT-PCR. Each value shown is the n-fold
induction over the mRNA level in uninfected macrophages. (D) Splicing of the XBP-1 transcript in
BMDM infected with B. abortus strains or treated with tunicamycin for 24 h. An increase in spliced
XBP1 mRNA (XBP1-s) was observed in macrophages infected with wild-type B. abortus compared to
that in uninfected macrophages or macrophages infected with the vceC mutant (MDJ32). NI, not
infected. (E to G) Knockdown of IRE1 in BMDM. (E) Quantification of IRE1 in BMDM treated with
either control or IRE1-specific siRNApools by densitometric analysis ofWestern blots. (F) Intracellular
numbers of CFU of B. abortus strains treated with control or IRE1-specific siRNA pools. (G) Induction
of IL-6 24 h after B. abortus infection of BMDM treated with IRE1-specific or control siRNA pools. The
results shown are means standard errors of data from three independent experiments. The Student
t test was used to analyze differences between individual sets of data. **, P  0.01. ns, no significant
difference.
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binds to unfolded stretches of proteins, with a preference for hy-
drophobic domains (33). Thus, the interaction of VceC with BiP
could be a result of its localization in the ER, rather than a specific
mechanism for initiating the UPR. An alternate interpretation of
our results is that an activity of VceC that is independent of bind-
ing to BiPmay provide a stimulus that induces theUPR.One piece
of evidence that suggests that the VceC-BiP interaction may be
relevant for induction of the UPR is the disorganization of ER
structure that was observed on the expression of VceC in HeLa
cells (Fig. 4), which resembled the phenotype observed when BiP
was knocked down in cells with siRNA (48). Our results do show,
however, that localization of VceC to the ER was required for
induction of NF-B, as we observed no activation of this pathway
by anN-terminally truncated VceC variant that failed to target the
ER (Fig. 7A).
ER stress is known to elicit both apoptotic and autophagic
pathways. InfectionwithB. suis andB.melitensis is associatedwith
inhibition of cell death pathways (49, 50), suggesting that other
signals in addition to UPR induction may be needed to induce
apoptosis. B. abortus infection has recently been shown to induce
selective autophagy of BCVs by a noncanonical pathway (23).
However, deletion of vceC did not affect this intracellular stage of
the bacterium’s cycle, since a vceCmutant still formed aBCVs (see
Fig. S2 in the supplemental material), suggesting that this protein
is not essential for the induction of this novel autophagic pathway
by B. abortus or that it may work redundantly with other, as-yet-
unidentified, effectors to elicit this pathway. In contrast, both the
induction of XBP-1 splicing by VceC and the dependence of the
VceC-dependent inflammatory response on IRE1 suggest that the
IRE1 arm of the UPR is activated by VceC (Fig. 6E to G; see Fig. S3
in the supplemental material). Interestingly, IRE1 was shown pre-
viously to be required for the intracellular replication of B. abor-
tus, since IRE1 deficiency rendered Drosophila S2 cells or murine
embryonic fibroblasts nonpermissive for B. abortus replication
(51). It should be pointed out that unlike nonphagocytic cells, the
IFN--activated BMDM in our study are not highly permissive of
the intracellular replication of B. abortus; therefore, our results do
not address whether IRE1 is required for intracellular replication.
However, if IRE1 is also required for the replication of B. abortus
in macrophages, then additional B. abortus factors must act on
IRE1 to promote intracellular replication, since inactivation of
vceC alone did not affect the replication competence of B. abortus
in a more permissive macrophage cell line, J774 (see Fig. S1C in
the supplemental material).
The picture emerging from this and previous studies is that the
UPR represents a surveillance pathway that detects both viral and
bacterial intrusions into the ER and induces inflammatory re-
sponses to infection. While UPR-induced NF-B signaling may
represent a novel host surveillance pathway for bacterial effectors,
B. abortus seems to exploit this pathway to its benefit in vivo, since
VceC provided a modest advantage for long-term colonization of
themouse. Perhapsmore importantly, T4SS-mediated inflamma-
tion leads to abortion in a mouse model (52). T4SS-mediated
inflammationmight thus increase the fitness ofB. abortus, because
abortion is the main route of pathogen transmission within its
natural bovine animal reservoir (53).
MATERIALS AND METHODS
Bacterial strains and plasmids. For the B. abortus and E. coli strains used
in this study, see Table S1 in the supplemental material. B. abortus 2308
was used as the wild-type strain. Brucella strains were cultured on tryptic
soy agar (Difco/Becton, Dickinson, Sparks, MD), in tryptic soy broth
(TSB) with appropriate antibiotics, or in modified E medium (26). E. coli
strains were grown in lysogeny broth that was solidified with agar as
needed. Antibiotics were used at the following concentrations for E. coli
andB. abortus: carbenicillin, 100g/ml; kanamycin, 100g/ml; chloram-
phenicol, 30 g/ml. E. coli and B. abortus were grown at 37°C. Experi-
ments with B. abortus were performed at biosafety level 3 by following
standard operating procedures reviewed and approved by Institutional
Biosafety Committees, in compliance with NIH guidelines and CDC Se-
lect Agent Program regulations. DNA techniques were performed accord-
ing to standard protocols.
Construction of plasmids. For the plasmids used in this study, see
Table S1 in the supplemental material. For the primers used to generate
recombinant constructs, see Table S2 in the supplemental material. For
technical reasons, all constructs containing vceC lack the first 12 nucleo-
tides from the predicted start codon and therefore, unless indicated oth-
erwise, all recombinant VceC proteins start at amino acid 5.
Confocalmicroscopy.HeLa cells were seeded on 12-mmcoverslips in
24-well plates at 5  104 cells per well. After 24 h, cells were transfected
with the different constructs containing vceC fusions (see Table S1 in the
supplemental material) using 0.5 g of plasmid DNA at a ratio of 2 g of
DNA to 4l of FugeneHD (Roche). After another 24 h, cells were washed
three times with phosphate-buffered saline (PBS) and fixedwith 3%para-
formaldehyde for 10min at 37°C. Fixed cells werewashed again twice, and
NH4Cl (50 mM) was added for 10 min. Then, coverslips were incubated
for 30 min in blocking buffer (PBS with 10% horse serum and 0.1%
saponin [Sigma]) and for 40 min in blocking buffer containing primary
antibodies. After three washes in PBS, the coverslips were incubated for
40 min in blocking buffer containing secondary antibodies. Finally, the
coverslipswerewashed three times in PBS and once inwater andmounted
on glass slides using Mowiol (Calbiochem). The primary antibodies used
were mouse anti-hemagglutinin (HA) or anti-Myc (Covance), rabbit
anti-calreticulin (Thermo Scientific), rabbit anti-giantin (Covance),
mouse anti-BiP (BD BioScience), and rat anti-VceC (Genovac) antibod-
ies. The secondary antibodies used were donkey anti-mouse (Alexa 488 or
Alexa 647 conjugated), donkey anti-rabbit (Alexa 488 or Alexa 568 con-
jugated) (from Invitrogen), and Cyanin5-conjugated anti-rat (Jackson
ImmunoResearch) antibodies.
IP. For IP experiments, 15 10-by-10-cm dishes containing 8  105
HeLa cells each were transfected with vceA- or vceC-containing vectors.
FIG 7 Activation of NF-B byHA-VceC but not by VceC38-418. HEK293 cells
were transfected for 48 h with a vector for the expression of full-length HA-
VceC or truncatedHA-VceC38-418. As a negative control, cells were transfected
with an empty vector, and as a positive control for NF-B activation, cells were
transfected with an empty vector and treated with 2 g/ml tunicamycin. The
results shown are means  standard deviations of three independent experi-
ments.
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For each dish, 6 g of plasmid DNA was added to 600 l Dulbecco’s
modified Eagle’s medium and 18 l of Fugene HD transfection reagent
was added. After 15 min, this mixture was added to each dish, and 40 h
later, cells were scraped from the dishes and washed twice with cold PBS.
The cells were lysed by adding lysis buffer (PBS, 50 mM Tris-HCl
[pH 7.6], 150 mMNaCl, 0.1% [vol/vol] NP-40, 1 mMEDTA) containing
phosphatase inhibitor (1:100) and protease inhibitor III (1:500) (Calbio-
chem). After 15 to 25min on ice, the lysates were centrifuged at 3,000 g,
for 15min at 4°C. The supernatantwas thenprecleared by incubationwith
70 l 50% protein A agarose (Amersham) slurry for 1 h at 4°C on a
rotator. The lysate was centrifuged at 1,000  g for 2 min to pellet the
agarose, and the supernatant was collected. To the supernatant, 7.5 l of
anti-green fluorescent protein (GFP; Invitrogen) or anti-Myc (Covance)
antibody was added (0.5 g antibody per plate) and incubated while ro-
tating for 1 h at 4°C. Then, 70 l protein A agarose slurry was added for 1
to 2 h. The agarose was pelleted by low-speed centrifugation. For some
samples, another 5l of anti-GFP or anti-Myc antibody was added to the
supernatant for a second round of IP similar to that described above. The
agarose was washed four times with lysis buffer and then once with lysis
buffer without NP-40. A 30-l volume of hot 2 SDS sample buffer was
added, and eluates of both rounds of IP were pooled together and boiled
for 5 min. Some eluates (Fig. 3A) were separated by 4 to 15% SDS-PAGE.
Bands were excised and sent to the Taplin Mass Spectrometry Facility
(Harvard University) for analysis by microcapillary tandem mass spec-
trometry (MS).Other eluates (Fig. 3C)were sent to theUCDavisGenome
Center Proteomics Facility for trypsin digestion and identification of pep-
tide fragments by liquid chromatography (LC)-MS analysis.
Infection of mice. Female C57BL/6 mice were obtained from The
Jackson Laboratory (Bar Harbor, ME) and used at an age of 4 to 6 weeks.
For infection experiments, groups of four or five mice were inoculated
intraperitoneally (i.p.) with 0.2 ml of PBS containing a 1:1 mixture of 2
105 CFU of wild-type B. abortus and 2  105 CFU of MDJ32 (vceC mu-
tant). Infected mice were held in microisolator cages in a biosafety level 3
facility. At appropriate time points, mice were euthanized and tissue col-
onization levels were determined as described previously (11). All animal
experiments were approved by the University of California, Davis, Insti-
tutional Laboratory Animal Care and Use Committee and were con-
ducted in accordance with institutional guidelines.
Infection of mouse BMDM. BMDM were obtained from C57BL/6
mice (Jackson) and were differentiated from bone marrow as previously
described (11). BMDMwere infected with B. abortus 2308, the virB2mu-
tant (ADH3), the vceCmutant (MDJ32), or the complemented vceCmu-
tant (MDJ71) at a multiplicity of infection (MOI) of 300:1. Gentamicin-
resistant bacteria were quantified at various time points as described
previously (11).
RNA isolation and qRT-PCR. RNA was isolated from macrophages
infected as described above, using Tri-reagent (Molecular Research Cen-
ter). One microgram of RNA was reverse transcribed in a final volume of
50 l to cDNA using murine leukemia virus reverse transcriptase (Ap-
plied Biosciences). For quantitative reverse transcription (qRT)-PCR, the
cDNA was used combined with primer pairs for mouse beta-actin (for
threshold cycle value correction), IL-6, BiP, or Sec61 (see Table S2 in the
supplemental material) and SYBR green master mix (Applied Biosci-
ences).
XBP-1 splicing assay. Mouse BMDM were infected with B. abortus
strains or treated with 3.5 g/ml tunicamycin (Sigma), and RNA was
isolated and reverse transcribed to cDNA as described above. To visualize
the splicing of XBP-1, a protocol developed by the Ron laboratory was
used (27). PCR was performed in a total volume of 50 l containing 2 l
cDNA, primers mXBP1-F and mXBP1-R at 10 pM each, and PCR Super-
mix (Invitrogen) by using the following PCR program: 94°C for 4min; 35
cycles of 10 s at 94°C, 30 s at 63°C, and 10 s at 72°C; and 72°C for 10 min.
PCR products of spliced and unspliced fragments were resolved on a 5%
polyacrylamide gel in Tris-borate-EDTA.
ELISA. IL-6 and TNF- secretion by infected mouse BMDM into the
medium was measured by an enzyme-linked immunosorbent assay
(ELISA) from eBioscience (mouse IL-6) or BioLegend (mouse TNF-)
according to the manufacturer’s protocol.
Western blotting. For detection of BiP/Grp78, the primary antibody
used was a mouse anti-BiP antibody (BD Bioscience) and the secondary
antibody used was a horseradish peroxidase (HRP)-conjugated goat anti-
rabbit (Bio-Rad) or anHRP-conjugated goat anti-mouse (Jackson Immu-
noResearch) antibody.
Knockdown of ern, encoding IRE1, in BMDM.Control nontargeting
pool and ERN1-targeting pool small interfering RNAs (siRNA) were pur-
chased fromDharmacon.Mouse BMDMwere transfectedwith anAmaxa
Nucleofector and an Amaxa mouse macrophage Nucleofector kit
(Lonza). Cells were seeded at 4  105 per well, and 24 h later they were
infected at an MOI of 300:1. At 24 h p.i., cells were washed once and
samples were taken for CFU enumeration, ELISA, and Western blotting.
To determine the efficiency of inositol-requiring transmembrane (TM)
kinase/endonuclease 1 (IRE1) knockdown, Western blots were probed
with anti-IRE1 antibodies (Cell Signaling). The results shown are averages
of three independent experiments.
Luciferase assay.HEK293 cells were seeded into 48-well plates at 40%
confluence. The next day, cells were transfectedwith 200 ng of pCMV-HA
plasmid (empty or encoding sipA, vceC, or VceC38-418) by using Fugene
HD (Promega) or treated with 2 g/ml tunicamycin (Sigma). Cells were
also transfected with 25 ng pNFkB luciferase reporter construct and 25 ng
pLacZ (a lacZ reporter to correct for transfection efficiency). Cells were
then incubated for 48 h at 37°C in 5%CO2. Cells were washed three times
in PBS and lysed by freezing at80°C and defrosting. A 10-l volume of
the lysate was transferred into a 96-well white OptiPlate (PerkinElmer),
and 50l of luciferase assay solution (Promega) was added shortly before
luciferase bioluminescence was measured with the luciferase assay system
(Promega) and a luminometer. For normalization of transfection effi-
ciency, -galactosidase activity (measured with an assay from Promega)
was used to adjust luciferase values (28).
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